Human Genome Research — CFDA 93.172

Genome-research obligations at $3.19 billion

USAspending.gov records $3,188,700,434.55 in obligations under CFDA 93.172. One thousand one hundred eighteen awards produce that stock. A simple average is about $2.85 million per award — typical of multi-year biomedical research grants rather than state block grants. That average is a quotient of two packet totals, not a typical sequencing-project budget.

The assistance-listing title is HUMAN GENOME RESEARCH. CFDA 93.172 is the identifier. Other institute listings tagged under other CFDA numbers are not mixed into the $3.19 billion. Combining those codes would invent a combined genomics total this packet does not contain.

274 recipients across 41 states

Two hundred seventy-four recipients share 1,118 awards, or about 4.1 award records per recipient on average. Splitting $3.19 billion evenly would assign about $11.6 million per recipient. That pattern matches a research portfolio in which institutions hold several concurrent awards. The packet does not list the 274. Recipient count is the organizational headcount, not a census of investigators or genomes.

Forty-one states in the geographic count show broad coding without covering every coded jurisdiction. Research dollars still concentrate at large biomedical campuses. The state count does not flatten those differences. Place-of-performance amounts are on the program table.

Award count is not a genome count

Among research listings, 93.172 is a mid-density file: 1,118 rows against 274 recipients. Renewals and supplements can inflate award count relative to unique projects. Award count is therefore a weak proxy for “number of genome studies.” Recipients (274) tell you how many named organizations sit on the extract; awards (1,118) tell you how many assistance rows were stored.

The packet does not report sequences produced, patient enrollments, or publication counts. Citing 1,118 as genomes or papers would be a unit error. Keep the units straight: dollars, awards, recipients, states.

Obligations versus research outlays

The $3.19 billion is an obligation total from USAspending.gov. Outlays — cash paid against human-genome research awards — are not in the packet. A laboratory can show a large obligation stock while draws follow a multi-year grant calendar. Deobligations and upward adjustments both move the total. A remaining-balance question is an outlay question this extract does not answer.

Use CFDA 93.172 to size the Human Genome Research listing in the assistance file. Do not use it as a sequencing-progress dashboard. Those series live elsewhere. This page reports the obligation book tagged 93.172.

What the 93.172 tables omit

The Human Genome Research hub lists award-backed obligations from USAspending.gov. It is not a sequence archive, not a patient census, and not a publication index. Series that never appear as assistance awards will not show up in the $3,188,700,434.55. That omission is definitional rather than a gap in the 1,118 award rows.

Place-of-performance on 41 states is a coding field. Read the program page before treating those cells as equal shares. Recipient dollars, if shown on the hub, are still obligation amounts, not cash already spent on sequencers or staff.

Where the 93.172 table lives

The Human Genome Research program page overlays these four facts. The all-programs index ranks 93.172 among other assistance listings. Agency pages show awarding-agency rollups that may include this CFDA among other health-research listings. For 93.172 only, start on the program page.

CFDA 93.172’s 1,118 awards spread $3,188,700,434.55 across 274 recipients and 41 states. Quote award count as a record count, recipient count as the organizational headcount, and dollars as obligations from USAspending.gov. About 4.1 award records per recipient is the density story on this listing. Outlays remain a separate column. Source: USAspending.gov assistance awards.

CFDA 93.172 is indexed at $3,188,700,434.55 in obligations, 1,118 awards, 274 recipients, and 41 states on USAspending.gov. Human Genome Research should be cited on that CFDA row alone. The $3.19 billion figure sizes the listing in the assistance file. It does not convert obligations into outlays, and it does not convert award count into a service, patient, student, or project census.

Readers who need the overlay tables should start on the program page for CFDA 93.172, then rank the listing on the all-programs index. Agency pages show awarding-agency rollups that may include this CFDA among other listings; they do not replace the $3,188,700,434.55 obligation stock. Keep the four facts together when quoting Human Genome Research: dollars as obligations from USAspending.gov, award count as a stored-row count, recipient count as the organizational headcount (including 0 when the extract stores none), and the state figure as a geographic coding count.

Questions

How much is obligated for Human Genome Research?

USAspending.gov records $3,188,700,434.55 in obligations for CFDA 93.172. SpendingVault indexes 1,118 awards, 274 recipients, and 41 states. The figure is an obligation sum from assistance awards, not an outlay and not a genome count. CFDA 93.172’s $3.19 billion is the USAspending obligation stock.

How many awards does CFDA 93.172 carry?

The listing shows 1,118 awards against 274 recipients, or about 4.1 award records per recipient. A simple average is about $2.85 million per award. Award count is not a sequence or patient count. Recipient dollars are on the program page.

How many organizations receive 93.172 awards?

The extract lists 274 recipients. Those are organizational recipients on assistance awards tagged 93.172. Geographic coding covers 41 states. The packet does not name the 274 or publish scientific output. Recipient count is the organizational headcount. CFDA 93.172’s $3.19 billion on 1,118 awards, with 274 recipients and 41 states in this aggregate, is the USAspending obligation stock.

Is $3.19 billion already spent on genome research?

Not necessarily. Obligations are commitments. Outlays are payments. CFDA 93.172’s indexed total is the obligation stock from USAspending.gov. This page does not report cash drawn, remaining balances, or sequences produced. The $3.19 billion on 1,118 awards is the obligation figure.